Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-di
about
Blood cells: an historical account of the roles of purinergic signallingHeat shock protein 90 inhibitors reduce trafficking of ATP-gated P2X1 receptors and human platelet responsiveness.MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in miceP2X1 stimulation promotes thrombin receptor-mediated platelet aggregation.Purinergic control of inflammation and thrombosis: Role of P2X1 receptorsEvidence for shear-mediated Ca2+ entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line.Amplification of human platelet activation by surface pannexin-1 channels.ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMPThe impact of commercially available purinergic ligands on purinergic signalling research.The stress of maternal separation causes misprogramming in the postnatal maturation of rat resistance arteries.Platelet P2 receptors: old and new targets for antithrombotic drugs.Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli.P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1The P2X1 ion channel in platelet function.The unique contribution of ion channels to platelet and megakaryocyte function.Identification of human P2X1 receptor-interacting proteins reveals a role of the cytoskeleton in receptor regulation.P2 receptors and platelet function.The P2X1 receptor and platelet function.Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosisP2X1, P2X4, and P2X7 Receptor Knock Out Mice Expose Differential Outcome of Sepsis Induced by α-Haemolysin Producing Escherichia coliMolecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.Mechanistic insights from resolving ligand-dependent kinetics of conformational changes at ATP-gated P2X1R ion channels.Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation.Effect of FGFR inhibitors on chicken limb development.Antiplatelet drugs
P2860
Q26799623-E85E86DE-30A6-48EE-9F31-A826F17291ACQ30525479-A9D90759-A0AF-41E8-96BE-29E97A876F6EQ33225547-9FB7D689-37B5-43F0-8BC3-EA80A4FFD989Q33240895-DDBBD8C4-68CA-440F-A7FD-9967B3D334DCQ33420664-1C5BA5BE-CAC7-482E-8A8F-B404D3843147Q33753349-C838E6F4-A6E8-4524-818C-3043AA603757Q34548535-83537910-2137-4DA3-97D0-256CAF86037EQ34796480-8BAFE2E4-7E03-4ACB-8DD6-39AE2F65C155Q35693550-4BDD0F2C-7439-47AB-AE89-C2A2D44C9523Q36339435-EB2A38E4-5AF0-490C-86ED-A11D8B61A566Q36691632-81870477-2C3A-4B9C-BF4B-E976EB6A5EB0Q37341915-0A7AF1A0-EF2A-4A47-96F4-B6F2CF7D1F8FQ37468664-EB34778D-C180-49A9-B5AA-FEB78DC33C01Q37702209-F4EB22D7-F50C-4563-9BA4-CADA27C5E5EDQ38022257-3B2EC3A3-8D5B-4521-9040-826BD6EEB6EBQ38263996-02961B07-F5FF-4D51-91E1-2346A310E9E5Q38306634-B58B3CBD-A400-42B3-BA43-D2E0FE4A1B1AQ38306728-0BBF8C88-2728-41F3-B315-A41EFAB55EDAQ38717607-D6917EF4-B289-48F6-AF58-B17D48FD2939Q38827553-3CD7CCB0-4519-40B5-92AB-C466FCB1703CQ40725974-BE76D9BF-E244-4B50-9315-6ECA53858A07Q41063256-6A5AB529-B1F3-4C87-B2FA-9DCCCA41089AQ41893172-C0C62192-0B0E-4BDB-89D5-66A25B7D98DEQ50177876-D6CCEAF7-768E-4478-9E70-A3AE8BE601D1Q54317817-4E987D66-9EA4-4495-9EAE-6093DF7BF8BBQ58481433-685CBE01-D2AA-48C1-93C3-8F3DD3AF61F2
P2860
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-di
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@ast
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@en
type
label
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@ast
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@en
prefLabel
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@ast
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@en
P2093
P356
P1476
Inhibition of platelet functio ...... mino)))tetrakis-benzene-1,3-di
@en
P2093
Béatrice Hechler
Christian Gachet
Heiko Ullmann
Maddalena L Zighetti
Marco Cattaneo
Matthias U Kassack
Richard Evans
Stéphanie Magnenat
P304
P356
10.1124/JPET.105.084673
P407
P577
2005-03-25T00:00:00Z